Alı Veral

1.5k total citations
77 papers, 1.1k citations indexed

About

Alı Veral is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Alı Veral has authored 77 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 28 papers in Surgery and 12 papers in Oncology. Recurrent topics in Alı Veral's work include Lung Cancer Treatments and Mutations (10 papers), Salivary Gland Tumors Diagnosis and Treatment (8 papers) and Oral Health Pathology and Treatment (7 papers). Alı Veral is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Salivary Gland Tumors Diagnosis and Treatment (8 papers) and Oral Health Pathology and Treatment (7 papers). Alı Veral collaborates with scholars based in Türkiye, United States and United Kingdom. Alı Veral's co-authors include Nesrin Moğulkoç, Paul Bishop, Coşkun Özcan, Özen K. Başoğlu, Yı́ldı́z Erhan, Christopher Pickering, Jim Egan, Murat Kapkaç, Rasih Yılmaz and E. Kara and has published in prestigious journals such as International Journal of Molecular Sciences, CHEST Journal and Cancers.

In The Last Decade

Alı Veral

67 papers receiving 998 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alı Veral Türkiye 16 499 357 249 197 120 77 1.1k
Gianluca Sambataro Italy 20 515 1.0× 297 0.8× 288 1.2× 415 2.1× 114 0.9× 102 1.3k
Alessandra Soriano Italy 24 469 0.9× 208 0.6× 186 0.7× 212 1.1× 72 0.6× 68 1.5k
Mary S. Richardson United States 24 335 0.7× 689 1.9× 261 1.0× 318 1.6× 40 0.3× 58 1.7k
Lida Radfar United States 19 86 0.2× 244 0.7× 523 2.1× 123 0.6× 62 0.5× 45 1.1k
Florian Kollert Germany 19 870 1.7× 148 0.4× 374 1.5× 189 1.0× 48 0.4× 51 1.6k
Metin Önerci Türkiye 21 204 0.4× 808 2.3× 167 0.7× 159 0.8× 86 0.7× 75 1.5k
Richard Carter United States 14 432 0.9× 193 0.5× 464 1.9× 240 1.2× 28 0.2× 26 1.2k
Nabil Fuleihan Lebanon 17 151 0.3× 388 1.1× 158 0.6× 75 0.4× 154 1.3× 54 841
Gökhan Gedikoğlu Türkiye 21 379 0.8× 426 1.2× 66 0.3× 203 1.0× 20 0.2× 103 1.4k
Joel B. Epstein Canada 10 413 0.8× 201 0.6× 90 0.4× 204 1.0× 35 0.3× 11 1.0k

Countries citing papers authored by Alı Veral

Since Specialization
Citations

This map shows the geographic impact of Alı Veral's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alı Veral with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alı Veral more than expected).

Fields of papers citing papers by Alı Veral

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alı Veral. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alı Veral. The network helps show where Alı Veral may publish in the future.

Co-authorship network of co-authors of Alı Veral

This figure shows the co-authorship network connecting the top 25 collaborators of Alı Veral. A scholar is included among the top collaborators of Alı Veral based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alı Veral. Alı Veral is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Güneri, Pelin, et al.. (2025). Is Dysplasia the Sole Determinant of the Prognosis in Oral Potentially Malignant Disorders?. Journal of Oral Pathology and Medicine. 54(4). 248–250. 2 indexed citations
3.
Göksel, Tuncay, Su Özgür, Aslı Teti̇k Vardarli, et al.. (2024). Prognostic and predictive role of liquid biopsy in lung cancer patients. Frontiers in Oncology. 13. 1275525–1275525. 2 indexed citations
4.
Asadi, Milad, et al.. (2023). Salivary Lipids of Patients with Non-Small Cell Lung Cancer Show Perturbation with Respect to Plasma. International Journal of Molecular Sciences. 24(18). 14264–14264. 4 indexed citations
5.
Palamar, Melis, et al.. (2023). Impression Cytologic Evaluation of the Conjunctiva in Patients Treated with Topical 1% Voriconazole. Turkish Journal of Ophthalmology. 54(1). 1–4.
6.
Etıt, Demet, Gözde Yazıcı, Alı Veral, et al.. (2023). The effect of P53 expression and smoking/alcohol in P16(+) and P16(–) oropharyngeal carcinoma and risk classification: the Turkish Society of Radiation Oncology Head & Neck Study Group 01-002. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 136(1). 80–90.
8.
Vardarli, Aslı Teti̇k, Levent Pelit, Ayça Aykut, et al.. (2020). * Concordance in molecular genetic analysis of tumour tissue, plasma, and exhaled breath condensate samples from lung cancer patients. Journal of Breath Research. 14(3). 36001–36001. 9 indexed citations
9.
Palamar, Melis, et al.. (2019). The effect of topical voriconazole on conjunctiva in rats as revealed by histopathology and immunohistochemistry. Journal of Chemotherapy. 31(5). 267–273. 1 indexed citations
10.
Koyuncu, Banu Özveri, et al.. (2018). Evaluation of p53, Ki-67 and c-erb-B2 Expression in Normal Oral Epithelium, Dysplastic Epithelium, and Oral Squamous Cell Carcinoma. 3(1). 1–7. 2 indexed citations
11.
Ekren, Pervin Korkmaz, Nesrin Moğulkoç, Sait Eğrilmez, et al.. (2016). Conjunctival Biopsy as a First Choice to Confirm a Diagnosis of Sarcoidosis.. PubMed. 33(3). 196–200. 5 indexed citations
12.
Oruç, Nevin, et al.. (2015). Cystic fluid chromogranin A levels in different pancreatic cystic lesions. The Turkish Journal of Gastroenterology. 26(6). 522–527. 1 indexed citations
13.
Veral, Alı, et al.. (2014). The prognostic value of p53 expression in negative surgical margins of early glottic carcinoma in the prediction of local recurrences. Acta Oto-Laryngologica. 134(5). 525–530. 5 indexed citations
14.
Şahin, Hilal, Naim Ceylan, Selen Bayraktaroğlu, et al.. (2012). Necrotizing Sarcoid Granulomatosis Mimicking Lung Malignancy: MDCT, PET-CT and Pathologic Findings. Iranian Journal of Radiology. 9(1). 37–41. 10 indexed citations
15.
Taşbakan, Mehmet Sezai, Oğuz Reşat Sıpahı, Dilek Yeşim Metin, et al.. (2010). Pansitopenik bir olguda rinoserebral ve akciğer mukormikozu ve aspergillozu. ANKEM Dergisi. 24(1). 42–45. 1 indexed citations
16.
Samancılar, Özgür, Alpaslan Çakan, Y. Cetin, et al.. (2007). Comparison of the Harmonic Scalpel and the Ultrasonic Surgical Aspirator in Subsegmental Lung Resections: An Experimental Study. The Thoracic and Cardiovascular Surgeon. 55(8). 509–511. 8 indexed citations
17.
Çağırıcı, Ufuk, et al.. (2006). [Surgical results of large cell neuroendocrine carcinoma of the lung].. PubMed. 54(1). 30–3.
18.
Ertan, Yeşim, Denız Nart, Tuncer Turhan, et al.. (2006). MİKSOPAPİLLER EPENDİMOM (10 OLGUNUN KLİNİKOPATOLOJİK DEĞERLENDİRMESİ). DergiPark (Istanbul University). 45(1). 13–18. 1 indexed citations
19.
Başoğlu, Özen K., et al.. (2003). Eosinophilic bronchitis as a cause of chronic cough. Respiratory Medicine. 97(6). 695–701. 40 indexed citations
20.
Erhan, Yı́ldı́z, Alı Veral, E. Kara, et al.. (2000). A clinicopthologic study of a rare clinical entity mimicking breast carcinoma: idiopathic granulomatous mastitis. The Breast. 9(1). 52–56. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026